Lv11
68 积分 2025-07-25 加入
FibroScan’s evolution: a critical 20-year review
14天前
已完结
The Optimal Cutoffs of Liver Stiffness Measurement for Staging Fibrosis in On-treatment Patients With Chronic Hepatitis B
18天前
已完结
Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort
18天前
已完结
Recent prevalence and trends of obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) among US adolescents: 1999 to 2020
18天前
已完结
Use of liver stiffness measurement for HCC risk stratification in metabolic dysfunction-associated steatotic liver disease
19天前
已完结
Association between longitudinal weight change and clinical outcome in individuals with MASLD
19天前
已完结
The Optimal Cutoffs of Liver Stiffness Measurement for Staging Fibrosis in On-treatment Patients With Chronic Hepatitis B
19天前
已关闭
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD
19天前
已完结
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis
21天前
已完结
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
1个月前
已完结
皖公网安备34019202002308
